日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/08/28 | 3,590 | 3,644 | 3,586 | 3,592 | -6 | -0.2% | 341,000 |
| 2026/08/27 | 3,572 | 3,610 | 3,567 | 3,598 | -9 | -0.2% | 285,400 |
| 2026/08/26 | 3,585 | 3,624 | 3,563 | 3,607 | +76 | +2.2% | 521,600 |
| 2026/08/25 | 3,564 | 3,586 | 3,530 | 3,531 | -92 | -2.5% | 546,000 |
| 2026/08/24 | 3,661 | 3,679 | 3,623 | 3,623 | -44 | -1.2% | 282,800 |
| 2026/08/21 | 3,680 | 3,690 | 3,654 | 3,667 | -30 | -0.8% | 251,700 |
| 2026/08/20 | 3,660 | 3,704 | 3,650 | 3,697 | +71 | +2% | 340,900 |
| 2026/08/19 | 3,645 | 3,658 | 3,583 | 3,626 | +10 | +0.3% | 283,300 |
| 2026/08/18 | 3,583 | 3,630 | 3,572 | 3,616 | +18 | +0.5% | 377,800 |
| 2026/08/17 | 3,676 | 3,677 | 3,581 | 3,598 | -42 | -1.2% | 298,400 |
| 2026/08/14 | 3,670 | 3,761 | 3,611 | 3,640 | +27 | +0.7% | 526,400 |
| 2026/08/13 | 3,646 | 3,648 | 3,570 | 3,613 | +10 | +0.3% | 250,300 |
| 2026/08/12 | 3,590 | 3,618 | 3,579 | 3,603 | +7 | +0.2% | 339,900 |
| 2026/08/10 | 3,618 | 3,634 | 3,576 | 3,596 | +17 | +0.5% | 285,900 |
| 2026/08/07 | 3,500 | 3,599 | 3,481 | 3,579 | +40 | +1.1% | 306,300 |
| 2026/08/06 | 3,474 | 3,543 | 3,456 | 3,539 | +66 | +1.9% | 334,000 |
| 2026/08/05 | 3,473 | 3,496 | 3,437 | 3,473 | ±0 | ±0% | 352,800 |
| 2026/08/04 | 3,446 | 3,535 | 3,437 | 3,473 | +50 | +1.5% | 593,600 |
| 2026/08/03 | 3,436 | 3,465 | 3,376 | 3,423 | +23 | +0.7% | 827,900 |
| 2026/07/31 | 3,453 | 3,494 | 3,400 | 3,400 | -95 | -2.7% | 1,789,800 |
| 2026/07/30 | 3,570 | 3,578 | 3,463 | 3,495 | -55 | -1.5% | 1,171,300 |
| 2026/07/29 | 3,578 | 3,590 | 3,461 | 3,550 | -30 | -0.8% | 1,809,000 |
| 2026/07/28 | 3,598 | 3,640 | 3,380 | 3,580 | -499 | -12.2% | 2,079,400 |
| 2026/07/27 | 4,029 | 4,079 | 4,008 | 4,079 | +13 | +0.3% | 276,700 |
| 2026/07/24 | 4,001 | 4,069 | 3,991 | 4,066 | +49 | +1.2% | 175,400 |
| 2026/07/23 | 4,030 | 4,060 | 4,010 | 4,017 | -2 | ±0% | 271,700 |
| 2026/07/22 | 4,078 | 4,088 | 3,995 | 4,019 | +11 | +0.3% | 244,000 |
| 2026/07/21 | 4,048 | 4,082 | 3,991 | 4,008 | -40 | -1% | 234,100 |
| 2026/07/17 | 4,007 | 4,048 | 3,982 | 4,048 | +58 | +1.5% | 264,700 |
| 2026/07/16 | 4,025 | 4,060 | 3,980 | 3,990 | -23 | -0.6% | 171,300 |
| 2026/07/15 | 4,061 | 4,077 | 3,980 | 4,013 | -40 | -1% | 210,500 |
| 2026/07/14 | 4,044 | 4,108 | 4,033 | 4,053 | +21 | +0.5% | 155,900 |
| 2026/07/13 | 4,062 | 4,095 | 4,019 | 4,032 | -50 | -1.2% | 156,900 |
| 2026/07/10 | 4,063 | 4,116 | 4,060 | 4,082 | -19 | -0.5% | 155,500 |
| 2026/07/09 | 4,098 | 4,115 | 4,060 | 4,101 | +17 | +0.4% | 175,300 |
| 2026/07/08 | 4,133 | 4,155 | 4,084 | 4,084 | -37 | -0.9% | 156,700 |
| 2026/07/07 | 4,130 | 4,179 | 4,117 | 4,121 | -35 | -0.8% | 217,300 |
| 2026/07/06 | 4,130 | 4,163 | 4,088 | 4,156 | +36 | +0.9% | 190,300 |
| 2026/07/03 | 4,149 | 4,172 | 4,105 | 4,120 | +36 | +0.9% | 167,400 |
| 2026/07/02 | 4,031 | 4,100 | 3,989 | 4,084 | +99 | +2.5% | 284,400 |
| 2026/07/01 | 3,988 | 4,030 | 3,971 | 3,985 | -31 | -0.8% | 197,400 |
| 2026/06/30 | 4,068 | 4,103 | 4,003 | 4,016 | -89 | -2.2% | 291,900 |
| 2026/06/29 | 4,115 | 4,122 | 4,038 | 4,105 | +56 | +1.4% | 358,800 |
| 2026/06/26 | 3,991 | 4,060 | 3,983 | 4,049 | +12 | +0.3% | 270,500 |
| 2026/06/25 | 4,076 | 4,087 | 4,022 | 4,037 | -10 | -0.2% | 234,000 |
| 2026/06/24 | 3,987 | 4,047 | 3,984 | 4,047 | +31 | +0.8% | 269,900 |
| 2026/06/23 | 3,960 | 4,029 | 3,932 | 4,016 | +41 | +1% | 273,300 |
| 2026/06/22 | 3,998 | 4,005 | 3,945 | 3,975 | +3 | +0.1% | 205,200 |
| 2026/06/19 | 3,965 | 3,992 | 3,954 | 3,972 | -51 | -1.3% | 346,700 |
| 2026/06/18 | 3,955 | 4,023 | 3,939 | 4,023 | +52 | +1.3% | 212,600 |
1～
50
件表示中 / 4015件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 359,200円 | +17.1% | +5.9% | 3.45% | 7.99倍 | 0.83倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 184,750円 | +6.6% | +4.3% | 2.27% | 14.83倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 378,400円 | +10.9% | -11.3% | 4.18% | 10.77倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 393,500円 | +11.1% | +6.8% | 2.16% | 9.14倍 | 1.09倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 292,000円 | - | - | 0.00% | - | 4.75倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
